Sierra Capital LLC grew its position in ARK Genomic Revolution ETF (NYSEARCA:ARKG – Get Rating) by 22.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,226 shares of the company’s stock after buying an additional 14,669 shares during the quarter. Sierra […]